The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women
Open accessAbstract
BACKGROUND: The Breast Cancer Risk Assessment Tool of the National Cancer Institute (NCI) is widely used for counseling and determining eligibility for breast cancer prevention trials, although its validity for projecting risk in African American women is uncertain. We developed a model for projecting absolute risk of invasive breast cancer in African American women and compared its projections with those from the Breast Cancer Risk Assessment Tool. METHODS: Data from 1607 African American women with invasive breast cancer and 1647 African American control subjects in the Women's Contraceptive and Reproductive Experiences (CARE) Study were used to compute relative and attributable risks that were based on age at menarche, number of affected mother or sisters, and number of previous benign biopsy examinations. Absolute risks were obtained by combining this information with data on invasive breast cancer incidence in African American women from the NCI's Surveillance, Epidemiology and End Results Program and with national mortality data. Eligibility screening data from the Study of Tamoxifen and Raloxifene (STAR) trial were used to determine how the new model would affect eligibility, and independent data from the Women's Health Initiative (WHI) were used to assess how well numbers of invasive breast cancers predicted by the new model agreed with observed cancers. RESULTS: Tables and graphs for estimating relative risks and projecting absolute invasive breast cancer risk with confidence intervals were developed for African American women. Relative risks for family history and number of biopsies and attributable risks estimated from the CARE population were lower than those from the Breast Cancer Risk Assessment Tool, as was the discriminatory accuracy (i.e., concordance). Using eligibility screening data from the STAR trial, we estimated that 30.3% of African American women would have had 5-year invasive breast cancer risks of at least 1.66% by use of the CARE model, compared with only 14.5% by use of the Breast Cancer Risk Assessment Tool. The numbers of cancers predicted by the CARE model agreed well with observed numbers of cancers (i.e., it was well calibrated) in data from the WHI, except that it underestimated risk in African American women with breast biopsy examinations. CONCLUSIONS: The CARE model usually gave higher risk estimates for African American women than the Breast Cancer Risk Assessment Tool and is recommended for counseling African American women regarding their risk of breast cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most existing traditional risk models were developed on predominantly White populations101,107 and have known limitations in predicting risk for other racial groups.108–111”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [110]
In the citing paper
“Indeed, race is used explicitly in popular prediction models that inform the need for osteoporotic33, breast34–37 and prostate cancer screening38,39; statin use for coronary heart disease prevention40,41 and other common decisions.”
From Predictably unequal: understanding and addressing concerns that algorithmic clinical prediction may increase health disparities (2020) · cites this paper as [36]
Citations
Cites
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Self-citationD'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Vogel, V. G. (2006) · JAMA · doi:10.1001/jama.295.23.joc60074 · Cited by 1,652
Self-citationEstimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214
Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence
Costantino, J. P., Gail, M. H., Pee, D., Anderson, S., Redmond, C. K., Benichou, J., & Wieand, H. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1541 · Cited by 765
Self-citationEthnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Self-citationRockhill, B., Spiegelman, D., Byrne, C., Hunter, D. J., & Colditz, G. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.358 · Cited by 618
Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma
Travis, L. B., Hill, D., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Pukkala, E., Lynch, C. F., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji290 · Cited by 425
Self-citationA family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data
WIEAND, S., GAIL, M. H., JAMES, B. R., & JAMES, K. L. (1989) · Biometrika · doi:10.1093/biomet/76.3.585 · Cited by 355
Self-citationChen, J., Pee, D., Ayyagari, R., Graubard, B., Schairer, C., Byrne, C., Benichou, J., & Gail, M. H. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj332 · Cited by 346
Self-citation
Cited by
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction
Yala, A., Lehman, C., Schuster, T., Portnoi, T., & Barzilay, R. (2019) · Radiology · doi:10.1148/radiol.2019182716 · Cited by 758
Tice, J. A., Cummings, S. R., Smith-Bindman, R., Ichikawa, L., Barlow, W. E., & Kerlikowske, K. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00004 · Cited by 537
Breast Cancer Screening and Diagnosis
Bevers, T. B., Anderson, B. O., Bonaccio, E., Buys, S., Daly, M. B., Dempsey, P. J., Farrar, W. B., Fleming, I., Garber, J. E., Harris, R. E., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0070 · Cited by 465
Metadata
- Authors
- Gail, M. H., Costantino, J. P., Pee, D., Bondy, M., Newman, L., Selvan, M., Anderson, G. L., Malone, K. E., Marchbanks, P. A., McCaskill-Stevens, W., Norman, S. A., Simon, M. S., Spirtas, R., Ursin, G., & Bernstein, L.
- Affiliations
- National Institutes of Health (US)
- Centers for Disease Control and Prevention (US)
- University of Southern California (US)
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-27
- Volume
- 99
- Issue
- 23
- Pages
- 1782-1792
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2111061352
- Cited by
- 356
- References
- 15
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 29 · 2023: 23 · 2022: 21 · 2021: 22 · 2020: 16 · 2019: 26 · 2018: 11 · 2017: 11 · 2016: 12 · 2015: 31 · 2014: 15 · 2013: 23 · 2012: 20
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- University Libraries (University of Maryland) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Digital Repository at the University of Maryland (University of Maryland College Park)
- Funders
- U.S. Department of Health and Human Services (U10-CA-37377, U10-CA-69974)
- University of Southern California (N01-HD-3-3175)
- Wayne State University
- University of Pennsylvania (N01-HD-3–3176)
- Emory University
- Barbara Ann Karmanos Cancer Institute
- National Institutes of Health
- Centers for Disease Control and Prevention (Y01‐HD‐7022)
- National Heart, Lung, and Blood Institute
- National Cancer Institute (U10 CA 12027, U10-CA37377, U10CA069651, U10CA037377, U10CA069974, U10 CA 69651, U10CA012027, U10-CA-69974)
- National Institute of Child Health and Human Development (N01-HD-3-3175)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (Y01 HD 7022, N01 HD 33174, N01-HD-3-3176, N01-HD-2-3168, N01 HD3-3175, N01 HD 23166)
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- invasive breast cancer risk, African American women, Breast Cancer Risk Assessment Tool, risk prediction model, care studies, age at menarche, family history of breast cancer, breast biopsy, STAR trial, Women's Health Initiative, risk calibration, risk counseling
- MeSH terms
- Adult, Aged, Biopsy, Black or African American, Breast Neoplasms, Female, Forecasting, Humans, Mammography, Mass Screening, Middle Aged, Tamoxifen, United States, Confounding Factors, Epidemiologic, Incidence, Logistic Models, Odds Ratio, Women's Health, Carcinoma, Ductal, Breast, SEER Program, Risk Assessment, Antineoplastic Agents, Hormonal, Estrogen Receptor Modulators, Raloxifene Hydrochloride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women. https://app.cochat.ai/papers/10.1093/jnci/djm223
- The paper
- Gail, M. H., Costantino, J. P., Pee, D., Bondy, M., Newman, L., Selvan, M., Anderson, G. L., Malone, K. E., Marchbanks, P. A., McCaskill-Stevens, W., Norman, S. A., Simon, M. S., Spirtas, R., Ursin, G., & Bernstein, L. (2007). Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djm223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.